Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 43Neoplasms 24Motor Activity 12Pain, Postoperative 9Colorectal Neoplasms 9Stomach Neoplasms 8Lung Neoplasms 8Fatigue 7Anxiety Disorders 6Pain 5Carcinoma, Hepatocellular 5Rectal Neoplasms 4Polycystic Ovary Syndrome 4Leukemia, Myeloid, Acute 4Depression 4Colonic Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Stomatitis 3Squamous Cell Carcinoma of Head and Neck 3Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Malnutrition 3Liver Neoplasms 3Head and Neck Neoplasms 3Agnosia 3Vomiting 2Urinary Incontinence 2

Interventions

Nivolumab 20Ipilimumab 10Surveys and Questionnaires 7Paclitaxel 7linrodostat 6Standard of Care 6Sirolimus 5Gemcitabine 5Bevacizumab 5temsirolimus 4relatlimab 4Pemetrexed 4Interviews as Topic 4Docetaxel 4Carboplatin 4ARRY-334543 4Vorinostat 3Erlotinib Hydrochloride 3Dasatinib 3Cetuximab 3regorafenib 2olaparib 2apatinib 2anlotinib 2abemaciclib 2Trastuzumab 2Sunitinib 2Sorafenib 2Olanzapine 2N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Cancer × Control Groups × Clear all
NCT04407013 2022-09-10

Enhanced Supportive Care for Advanced Cancer Patients: Evaluation of Standardized Care Pathway

Yonsei University

Phase NA Unknown
780 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡